A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2009.10.094 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!